Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors

Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors

Thumbnail Image
Download
Name

Liquid SOMA paper For Pub v1-1.pdf

Description
Accepted version
Size

2 MB

Format

Unknown

Checksum (MD5)

8d1f16e16c8707061bbe6ad09530b3d2

sword-2022-03-29T18:37:59.original.xml (130 B)
Original SWORD entry document
Author(s)
Abramson, Alex
•
Frederiksen, Morten Revsgaard
•
Vegge, Andreas
•
Jensen, Brian
•
Poulsen, Mette
•
Mouridsen, Brian
•
Jespersen, Mikkel Oliver
•
Kirk, Rikke Kaae
•
Windum, Jesper
•
Hubálek, František
more
Date Issued
August 2021
Journal
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Citation
Abramson, Alex, Frederiksen, Morten Revsgaard, Vegge, Andreas, Jensen, Brian, Poulsen, Mette et al. 2021. "Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors." Nature Biotechnology, 40 (1).
Version
Author's final manuscript
Abstract
Oral administration provides a simple and non-invasive approach for drug delivery. However, due to poor absorption and swift enzymatic degradation in the gastrointestinal tract, a wide range of molecules must be parenterally injected to attain required doses and pharmacokinetics. Here we present an orally dosed liquid auto-injector capable of delivering up to 4-mg doses of a bioavailable drug with the rapid pharmacokinetics of an injection, reaching an absolute bioavailability of up to 80% and a maximum plasma drug concentration within 30 min after dosing. This approach improves dosing efficiencies and pharmacokinetics an order of magnitude over our previously designed injector capsules and up to two orders of magnitude over clinically available and preclinical chemical permeation enhancement technologies. We administered the capsules to swine for delivery of clinically relevant doses of four commonly injected medications, including adalimumab, a GLP-1 analog, recombinant human insulin and epinephrine. These multi-day dosing experiments and oral administration in awake animal models support the translational potential of the system.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Massachusetts Institute of Technology. Media Laboratory
Massachusetts Institute of Technology. Department of Mechanical Engineering
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/141391.2
DOI of Published Version
https://doi.org/10.1038/s41587-021-01024-0
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.